Pharma Journalist - Page 915 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Körber AG plans to acquire Fargo Automation, Inc.

ERS Genomics agrees to license CRISPR/Cas9 to Knudra Transgenics

DNAtrix Announces First Patients Treated in Phase 2 Trial with DNX-2401 and KEYTRUDA

Portola expands collaboration with Daiichi to develop AndexXa in Germany

Nimbus secures $200m from Gilead for inhibitor program acquisition

Celgene and IBM Watson to develop new offering for patient safety monitoring

Bosch Packaging Expands Pharmaceutical Portfolio

FDA accepts for priority review Bristol-Myers’ sBLA for Opdivo for urothelial carcinoma use

Virtus sues FDA for clearing potassium chloride market of competition

VBL Therapeutics unveils plans to build new manufacturing facility in Israel